👉 Click Here to Order 👈 Opana ER (Oxymorphone Extended-Release) – Safety Notice Opana ER was an extended-release formulation of oxymorphon...
👉 Click Here to Order 👈
Opana ER (Oxymorphone Extended-Release) – Safety Notice Opana ER was an extended-release formulation of oxymorphone prescribed for severe, long-term pain requiring continuous opioid therapy. Due to serious safety concerns, including misuse and public health risks, Opana ER has been discontinued in the United States. It is no longer prescribed or recommended. Patients previously treated with Opana ER should consult their healthcare provider about alternative pain management options. Current pain treatment emphasizes safer opioid practices, non-opioid medications, and multidisciplinary approaches tailored to individual patient needs.